Other languages Johnson & Johnson Bulgaria S.E.

Equities

JNJ

US4781601046

Real-time Estimate Tradegate Other stock markets 01:02:30 01/06/2024 am IST			5-day change	1st Jan Change
135.2 ^EUR	-3.89%		0.00%	-11.49%

08:52pm	US lawmakers ask FBI for briefing on GenScript Biotech's links to China	RE
08:05pm	Sector Update: Health Care Stocks Advance Friday Afternoon	MT

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

US lawmakers ask FBI for briefing on GenScript Biotech's links to China	12:22am
Sector Update: Health Care Stocks Advance Friday Afternoon	11:35pm
Top Midday Stories: SQM, Codelco to Mine Lithium; Moderna Gets Approval for RSV Vaccine; Tesla Recalls Over 100,000 Cars; Icahn Amasses Stake in Caesars	11:00pm
Johnson & Johnson Executive Vice President, William N. Hait, M.D., Ph.D., to Retire, Effective September 2024	09:24pm
J&J : finalise l'acquisition de Shockwave Medical	07:12pm
Johnson & Johnson Closes Acquisition of Shockwave Medical	07:03pm
Johnson & Johnson Completes Acquisition of Shockwave Medical	06:33pm
Johnson & Johnson Completes Acquisition of Shockwave Medical	06:16pm
Johnson & Johnson completed the acquisition of Shockwave Medical, Inc. from a group of sellers.	31/05/2024
Sarepta Therapeutics to Replace Shockwave Medical in S&P MidCap 400	30/05
Johnson & Johnson : to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC) Press Release	30/05
Transcript : Johnson & Johnson Presents at Bernstein?s 40th Annual Strategic Decisions Conference, May-29-2024 01:30 PM	29/05
J&J : résultats encourageants dans le soin de la dépression	29/05
Johnson & Johnson's Phase 3 Trial of Seltorexant to Treat Major Depressive Disorder Meets Primary, Secondary Endpoints	29/05
J&J's treatment for depression succeeds in late stage study	29/05
Johnson & Johnson Announces Pivotal Study of Seltorexant Shows Statistically Significant and Clinically Meaningful Improvement in Depressive Symptoms and Sleep Disturbance Outcomes	29/05
NanoViricides (NNVC) Strengthens Drug Development Efforts with Calvert Labs Partnership and Announces Promising RSV Study Results	29/05
Sector Update: Health Care Stocks Fall Late Afternoon	29/05
Sector Update: Health Care Stocks Retreat Tuesday Afternoon	28/05
Sector Update: Health Care	28/05

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 11:00 pm IST